THC and Running: The Runner's High Connection

Body / Physical

Not Endorphins

A 2015 PNAS study proved the runner's high comes from endocannabinoids binding CB1 receptors, the same receptors THC targets, raising questions about whether cannabis enhances or disrupts that natural reward.

Fuss et al., PNAS, 2015

Fuss et al., PNAS, 2015

View as image

For decades, the runner's high was explained as an endorphin phenomenon. The story was simple and satisfying: sustained aerobic exercise triggers the release of endorphins, which bind to opioid receptors in the brain and produce euphoria. The problem is that this explanation was always incomplete, and more recent research has revealed it to be largely wrong.

The real story involves the endocannabinoid system, the same system that THC activates. This connection has not been lost on the running community, where cannabis use before and after runs has become increasingly common in legal states. But the relationship between THC, endocannabinoids, and the running experience is more nuanced than the superficial connection suggests.

The Paradigm Shift: Endocannabinoids, Not Endorphins

Body / Physical

The Runner's High: Endocannabinoids, Not Endorphins

Endorphins (Old Theory)

Source: Pituitary gland during exercise

Crosses BBB: No — too large

Receptors: Opioid receptors

Role: Pain relief, but NOT the euphoria source

Anandamide (New Theory)

Source: Produced during sustained aerobic activity

Crosses BBB: Yes — easily

Receptors: CB1 (same as THC)

Role: Euphoria, reduced anxiety, pain relief

THC (Exogenous)

Source: Cannabis consumption

Crosses BBB: Yes — easily

Receptors: CB1 (same as anandamide)

Role: Mimics anandamide — but may disrupt feedback

Concerns for Runners Using THC

CB1 downregulationRegular THC may dull natural runner's high over time

Impaired coordinationTrail running and uneven terrain become higher risk

Cardiovascular stackingTHC + exercise = double heart rate elevation

Self-assessmentCan't accurately judge fatigue or dehydration

Fuss et al., PNAS, 2015 • Sparling, 2003Runner's High: Endocannabinoids Not Endorphins

The endorphin hypothesis of the runner's high had a fundamental problem that was acknowledged quietly in exercise physiology for years before the alternative was proven. Endorphins are peptides. They are large molecules. And they do not readily cross the blood-brain barrier. While endorphin levels do rise in the bloodstream during exercise, the assumption that peripheral endorphins were responsible for a centrally mediated euphoric experience was always a stretch.

In 2015, Fuss and colleagues published a study in the Proceedings of the National Academy of Sciences (PNAS) that reframed the entire discussion. Using a mouse model, they demonstrated that the behavioral effects associated with the runner's high, specifically reduced anxiety and pain sensitivity after running, were blocked when CB1 cannabinoid receptors were knocked out or pharmacologically inhibited. Blocking opioid receptors, by contrast, did not eliminate these effects.

The implication was clear. The runner's high is primarily a cannabinoid phenomenon, not an opioid one.

This finding built on earlier work by Sparling and colleagues (2003), who documented that blood levels of anandamide, the primary endogenous cannabinoid, increase significantly after moderate-intensity aerobic exercise. Anandamide is a partial agonist at CB1 receptors. Unlike endorphins, it crosses the blood-brain barrier efficiently. When you run long enough at sufficient intensity, your body produces a cannabinoid that acts on the same receptors THC targets.

How Anandamide and THC Relate

Anandamide and THC are not identical molecules, but they share a critical functional property: both activate CB1 receptors in the brain. The key differences are in potency, duration, and regulation.

Anandamide is produced on demand, acts locally, and is rapidly broken down by the enzyme fatty acid amide hydrolase (FAAH). It is part of a tightly regulated feedback system. The body produces it, it does its job, and it is cleared. This makes the exercise-induced endocannabinoid response self-limiting. You get a burst of mood elevation and pain reduction during and after your run, and then levels return to baseline.

THC is more potent at CB1 receptors than anandamide, lasts much longer (hours versus minutes), and is not subject to the same rapid enzymatic degradation. When you introduce THC before a run, you are flooding the system with an exogenous agonist that mimics the molecule your body would produce naturally, but with stronger and more sustained activation.

This raises a question that has not been answered experimentally: does exogenous THC enhance the natural endocannabinoid response to running, or does it override it? If the body detects that CB1 receptors are already occupied by THC, does it still produce as much anandamide? The answer matters because it determines whether pre-run cannabis adds to the runner's high or substitutes for it.

What Runners Who Use Cannabis Report

Survey data from cannabis-using runners in legal states paints a consistent picture. Most report that low-dose cannabis before a run increases enjoyment, reduces the perception of effort, and helps them enter a more meditative or flow-like state during sustained running. Some describe the experience as an amplified version of the natural runner's high. Others say it simply makes the miles pass more pleasantly.

A 2019 study by YorkWilliams and colleagues at the University of Colorado Boulder found that cannabis users who co-used with exercise reported exercising more minutes per week than those who did not. Increased enjoyment was cited as the primary reason.

Ultra-running culture, in particular, has developed a visible relationship with cannabis. Long ultramarathon events, especially in the western United States, have an established subculture of runners who use small amounts of cannabis during training runs or even during races (where regulations permit). The appeal makes sense on paper: ultra-distance running involves hours of sustained effort where perceived exertion and pain management are central challenges. A substance that reduces both would seem advantageous.

But self-reports are not performance data. No controlled studies have measured whether cannabis-using runners actually perform better, worse, or the same as non-users in comparable conditions. The reported benefits are subjective and cannot be separated from expectancy effects, the social context of cannabis-friendly running groups, or simple placebo response.

Performance Effects: What the Evidence Shows

The limited controlled research on cannabis and aerobic performance does not support enhancement. A 1986 study by Steadward and Singh found that cannabis did not improve maximal exercise performance and may have slightly impaired it. VO2 max, the gold standard measure of aerobic fitness, has not been shown to improve with cannabis use in any published study.

THC does increase heart rate by 20 to 50 beats per minute acutely. During running, where heart rate is already elevated, this additive effect means your cardiovascular system is working harder at any given pace. For a trained runner, this may be tolerable. For someone with underlying cardiovascular risk factors, it is an added stress that serves no performance purpose.

The performance question may also be the wrong question. Many runners who use cannabis before running are not trying to run faster. They are trying to make the run more enjoyable. If cannabis increases the probability that someone completes a training run, stays consistent with their mileage, or finds running pleasant enough to maintain as a long-term habit, that has real value even if no single run is objectively faster.

The Replacement Hypothesis

One concern that has not been adequately studied is what happens to the natural endocannabinoid response in chronic cannabis users who run regularly. If THC is already occupying CB1 receptors before a run, does the body downregulate anandamide production during exercise? Does the natural runner's high diminish for regular cannabis users, creating a situation where they need exogenous THC to achieve what their body would have produced on its own?

This is speculative, but the underlying biology is concerning. Chronic THC exposure reliably produces CB1 receptor downregulation. Fewer available receptors means that the same amount of anandamide produces a weaker signal. It is plausible that regular cannabis users experience a blunted natural runner's high, which then reinforces the perceived need for THC to make running feel rewarding.

If this is the case, the dynamic is familiar from other contexts. A substance that mimics a natural reward signal eventually substitutes for it, and the natural system atrophies. This has not been studied in runners specifically, but it follows directly from established cannabinoid pharmacology.

Safety Considerations for Running While High

Running while impaired introduces several practical safety concerns that deserve honest discussion.

Trail running and uneven terrain. THC impairs balance and coordination. On technical trails with roots, rocks, and elevation changes, these impairments increase fall risk. Trail running already carries injury risk for sober runners. Adding impaired proprioception makes it worse.

Road running and traffic. Running on roads requires quick judgment about traffic patterns, intersection timing, and vehicle awareness. THC slows reaction time and can impair spatial judgment. Running in traffic while high is not the same risk category as running on a closed track.

Heat and hydration. Cannabis can impair thermoregulation, and THC's analgesic effects may mask early signs of heat exhaustion or dehydration. Running in hot conditions while high adds a layer of risk that sober runners do not face.

Cardiovascular stress. The additive heart rate effect of THC and running has been discussed, but it bears emphasis for runners with any cardiovascular risk factors, including those who may not know they have them. Young, apparently healthy runners occasionally experience cardiac events during exertion. Adding a substance that independently increases cardiac workload is not trivial.

Recognition of injury. Pain during running serves an important signaling function. It alerts you to emerging injuries before they become serious. THC's analgesic effects can mute these signals, allowing runners to push through pain that is telling them to stop. This can turn a minor strain into a significant injury.

The Natural System Is Already Remarkable

One of the most important takeaways from the endocannabinoid research is that the body has already built a sophisticated cannabinoid reward system for sustained aerobic exercise. Anandamide elevation during running is not a malfunction or an accident. It is an evolved mechanism, likely selected because it motivated our ancestors to sustain the physical activity necessary for persistence hunting and long-distance travel.

The runner's high is a feature, not a bug. It works without external supplementation. Whether adding THC to this system improves the experience in meaningful ways or introduces a dependency that undermines the natural system's elegance is a question that each runner who considers this choice should think about carefully.

The endocannabinoid system connects running and cannabis at a molecular level. That connection is real and scientifically fascinating. But molecular similarity does not mean that supplementing with THC is beneficial, neutral, or harmless. The natural system is tightly regulated for a reason. Introducing a more potent, longer-lasting agonist may feel good in the moment while subtly altering the system's calibration over time.

For runners who use cannabis, the evidence suggests keeping doses low, choosing safe environments, paying attention to whether the natural runner's high diminishes with chronic use, and being honest about whether the THC is serving the running or the running is serving the THC.

The Bottom Line

Endocannabinoid science of the runner's high and THC's relationship to it. Paradigm shift: endorphin hypothesis flawed (too large to cross BBB efficiently); Fuss 2015 PNAS — runner's high behaviors (reduced anxiety, pain sensitivity) blocked by CB1 knockout/inhibition, NOT by opioid receptor blockade; runner's high = cannabinoid phenomenon. Sparling 2003 NeuroReport — anandamide levels rise significantly during moderate-intensity aerobic exercise. Anandamide vs THC: both activate CB1; anandamide = produced on demand, acts locally, rapidly degraded by FAAH, self-limiting; THC = more potent, longer-lasting (hours vs minutes), not subject to same enzymatic clearance; THC floods system with stronger, sustained agonist. Unanswered question: does exogenous THC enhance, replace, or disrupt natural endocannabinoid exercise response? If body detects CB1 already occupied by THC, does it still produce anandamide? Runner reports: low-dose cannabis increases enjoyment, reduces perceived effort, meditative/flow state; YorkWilliams 2019 — cannabis co-users exercised more minutes/week. Ultra-running subculture notable. Performance: Steadward and Singh 1986 — no improvement; no VO2 max benefit; performance may be wrong question (adherence/enjoyment more relevant). Replacement hypothesis: chronic CB1 downregulation → blunted natural runner's high → dependency on THC for running reward. Safety: trail running (impaired balance), road running (reaction time/traffic), heat/hydration, cardiovascular stress, pain masking (push through injury).

Frequently Asked Questions

Is the runner's high caused by endocannabinoids or endorphins?

Primarily endocannabinoids. Fuss's 2015 PNAS study demonstrated that the behavioral effects of the runner's high — reduced anxiety and pain sensitivity — were blocked when CB1 cannabinoid receptors were knocked out but were NOT blocked when opioid receptors were inhibited. The endorphin hypothesis had a fundamental flaw: endorphins are too large to efficiently cross the blood-brain barrier. Anandamide, the endocannabinoid that rises during sustained running, crosses it readily and activates the same receptors THC targets.

Does THC enhance the runner's high?

No controlled studies have directly tested this. Runners who use cannabis before running commonly report increased enjoyment and a more meditative state, but these are self-reports vulnerable to expectancy effects. The unanswered scientific question is whether exogenous THC enhances the natural endocannabinoid response, replaces it, or disrupts the feedback loop. If THC is already occupying CB1 receptors, the body may not produce as much anandamide, meaning you are substituting a pharmacological experience for a natural one.

Can regular cannabis use blunt the natural runner's high?

This is a plausible concern based on established pharmacology. Chronic THC exposure causes CB1 receptor downregulation — fewer functional receptors. If the same amount of exercise-produced anandamide encounters fewer available receptors, the resulting signal is weaker. This could create a dependency dynamic where regular cannabis-using runners need exogenous THC to experience what their body would have produced naturally, because the natural reward system has been blunted by chronic supplementation.

Is it safe to run while high?

It depends on where and how you run. Flat, familiar routes with no traffic carry lower risk. Trail running with roots, rocks, and elevation changes becomes more dangerous because THC impairs balance and coordination. Road running in traffic is concerning because THC slows reaction time and spatial judgment. THC's analgesic effects can also mask pain signals that indicate emerging injuries, and the additive heart rate effect (THC plus running) adds cardiovascular stress. If you choose to run with cannabis, keep doses very low and choose the safest available environment.

Does cannabis help with ultra-running?

Ultra-running culture has a visible relationship with cannabis, with many athletes reporting that low-dose use helps with the psychological challenge of sustained multi-hour effort. The perceived exertion reduction and pain modulation from THC are theoretically relevant to ultra-distance events. However, no controlled performance data supports improved ultra-running outcomes with cannabis. The risks of impaired coordination on technical terrain, masked warning signs of overexertion or dehydration, and cardiovascular stress during prolonged effort are all present.

How does exercise affect THC already stored in my body?

THC is fat-soluble and accumulates in adipose tissue. Intense exercise mobilizes fat stores, which can release stored THC back into the bloodstream. Some people report feeling mildly high during intense exercise sessions days after their last cannabis use. This remobilization also means that exercise can cause previously stored THC to appear in blood or urine tests at unexpected times, which is relevant for anyone subject to drug testing.